From enigmatic to problematic
The new molecular genetics of childhood spinal muscular atrophy
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In recent years many of the most novel and fascinating surprises of the molecular revolution in medicine have emerged from investigations of the neuromuscular diseases. First came the discovery of the massive dystrophin gene in Duchenne muscular dystrophy, then the trinucleotide expansions of Kennedy syndrome and myotonic dystrophy, and, most recently, the dissimilar effects that excess or insufficient PMP22 gene dosage have in producing either Charcot-Marie-Tooth type 1A or hereditary neuropathy with liability to pressure palsies. Childhood spinal muscular atrophy (SMA)--the last major enigma of the common genetic neuromuscular disorders--may soon contribute to this list of surprises, since recent studies by three different groups [1-3] suggest a disorder characterized by its own distinctive molecular and genetic pathophysiology.
The genetics of SMA has been stunningly complex. Two groups of researchers looking for the SMA gene have reported evidence that supports unrelated but neighboring candidate genes, either of which, if discovered by itself, would have been hailed as a strong candidate. Each fulfills the criterion that has been useful in identifying candidate genes for other disorders: the close association between disabling mutations of the gene and the disease. But each of these reports harbors inconsistencies that require unconventional explanations to preserve the candidacy status of their gene--a suspension of disbelief that most investigators would be willing to grant were it not for the other group's findings. Some of the confusion surrounding the molecular genetics of SMA is no doubt due to our present incomplete understanding, but the very complexity of the SMA-containing region of chromosome 5 itself is responsible for many of the pathogenic mutations. Genetic complexity is thus at once the reason for our present confusion, the spur for further research, and a major cause of the disease.
The epidemiology and early nosology of SMA.
First described just over a century ago, SMA is, in its severe form, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Genotype-phenotype relationship in 2 SMA III patients with novel mutations in the Tudor domainM.J. Fraidakis, S. Drunat, T. Maisonobe et al.Neurology, February 08, 2012 -
Review
Molecular Biomarkers for Spinal Muscular AtrophyA Systematic ReviewAngela Navarrete-Opazo, Sheldon Garrison, Mindy Waite et al.Neurology: Clinical Practice, May 29, 2020 -
Articles
SMN1 gene, but not SMN2, is a risk factor for sporadic ALSP. Corcia, W. Camu, J. -M. Halimi et al.Neurology, August 23, 2006 -
Articles
SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALSJ. H. Veldink, S. Kalmijn, A. H. Van der Hout et al.Neurology, August 10, 2005